172 related articles for article (PubMed ID: 27788040)
1. Neuropeptide S receptor ligands: a patent review (2005-2016).
Ruzza C; Calò G; Di Maro S; Pacifico S; Trapella C; Salvadori S; Preti D; Guerrini R
Expert Opin Ther Pat; 2017 Mar; 27(3):347-362. PubMed ID: 27788040
[TBL] [Abstract][Full Text] [Related]
2. Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor.
Guerrini R; Salvadori S; Rizzi A; Regoli D; Calo' G
Med Res Rev; 2010 Sep; 30(5):751-77. PubMed ID: 19824051
[TBL] [Abstract][Full Text] [Related]
3. Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat.
Cifani C; Micioni Di Bonaventura MV; Cannella N; Fedeli A; Guerrini R; Calo G; Ciccocioppo R; Ubaldi M
Peptides; 2011 Jan; 32(1):44-50. PubMed ID: 20971145
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide S receptor: recent updates on nonpeptide antagonist discovery.
Dal Ben D; Antonini I; Buccioni M; Lambertucci C; Marucci G; Thomas A; Volpini R; Cristalli G
ChemMedChem; 2011 Jul; 6(7):1163-71. PubMed ID: 21452188
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1.
Camarda V; Ruzza C; Rizzi A; Trapella C; Guerrini R; Reinscheid RK; Calo G
Peptides; 2013 Oct; 48():27-35. PubMed ID: 23911665
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.
Camarda V; Rizzi A; Ruzza C; Zucchini S; Marzola G; Marzola E; Guerrini R; Salvadori S; Reinscheid RK; Regoli D; Calò G
J Pharmacol Exp Ther; 2009 Feb; 328(2):549-55. PubMed ID: 18971372
[TBL] [Abstract][Full Text] [Related]
7. [tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies.
Ruzza C; Rizzi A; Camarda V; Pulga A; Marzola G; Filaferro M; Novi C; Ruggieri V; Marzola E; Vitale G; Salvadori S; Guerrini R; Calo' G
Peptides; 2012 Apr; 34(2):404-11. PubMed ID: 22342393
[TBL] [Abstract][Full Text] [Related]
8. The Physio-Pharmacological Role of the NPS/NPSR System in Psychiatric Disorders: A Translational Overview.
Ghazal P
Curr Protein Pept Sci; 2016; 17(4):380-97. PubMed ID: 26680586
[TBL] [Abstract][Full Text] [Related]
9. Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor.
Ruzza C; Pulga A; Rizzi A; Marzola G; Guerrini R; Calo' G
Neuropharmacology; 2012 Apr; 62(5-6):1999-2009. PubMed ID: 22248636
[TBL] [Abstract][Full Text] [Related]
10. Central Neuropeptide S inhibits distal colonic transit through activation of central Neuropeptide S receptor in mice.
Han RW; Chang M; Peng YL; Qiao LY; Yin XQ; Li W; Wang R
Peptides; 2009 Jul; 30(7):1313-7. PubMed ID: 19540430
[TBL] [Abstract][Full Text] [Related]
11. Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation.
Clark SD; Kenakin TP; Gertz S; Hassler C; Gay EA; Langston TL; Reinscheid RK; Runyon SP
Neuropharmacology; 2017 May; 118():69-78. PubMed ID: 28267583
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor.
Ruzza C; Asth L; Guerrini R; Trapella C; Gavioli EC
Neuropharmacology; 2015 Oct; 97():1-6. PubMed ID: 25979487
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
Hoyer D; Bartfai T
Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation.
Filaferro M; Novi C; Ruggieri V; Genedani S; Alboni S; Malagoli D; Caló G; Guerrini R; Vitale G
Peptides; 2013 Jan; 39():16-20. PubMed ID: 23142110
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists.
Guerrini R; Camarda V; Trapella C; Calò G; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
J Med Chem; 2009 Jan; 52(2):524-9. PubMed ID: 19113861
[TBL] [Abstract][Full Text] [Related]
16. Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68.
Ruzza C; Rizzi A; Trapella C; Pela' M; Camarda V; Ruggieri V; Filaferro M; Cifani C; Reinscheid RK; Vitale G; Ciccocioppo R; Salvadori S; Guerrini R; Calo' G
Peptides; 2010 May; 31(5):915-25. PubMed ID: 20172007
[TBL] [Abstract][Full Text] [Related]
17. Evolutionary history of the neuropeptide S receptor/neuropeptide S system.
Valsalan R; Manoj N
Gen Comp Endocrinol; 2014 Dec; 209():11-20. PubMed ID: 24859256
[TBL] [Abstract][Full Text] [Related]
18. Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry.
Clark SD; Duangdao DM; Schulz S; Zhang L; Liu X; Xu YL; Reinscheid RK
J Comp Neurol; 2011 Jul; 519(10):1867-93. PubMed ID: 21452235
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]